Lupin gets EIR for Pithampur unit, from USFDA
Lupin has received the establishment investigation report (EIR) for the successful inspection of its Pithampur, Unit 1, from USFDA. The inspection was carried out during July...
Tag : Lupin
Lupin Outlook for the Week (Apr 02, 2018 – Apr 06, 2018)
EquityPandit’s Outlook for Lupin for the week (Apr 02, 2018 – Apr 06, 2018) : LUPIN: Lupin closed the week on positive note gaining around 0.20%....
Lupin Outlook for the Week (Mar 26, 2018 – Mar 28, 2018)
EquityPandit’s Outlook for Lupin for the week (Mar 26, 2018 – Mar 28, 2018) : LUPIN: Lupin closed the week on negative note losing around 3.70%....
Lupin gets USFDA approval for Tydemy tablets
Lupin has launched Tydemy tablets, which is suggested to be used by women for contraception. The company in a statement said that, the launch follows the...
Lupin Outlook for the Week (Mar 12, 2018 – Mar 16, 2018)
EquityPandit’s Outlook for Lupin for the week (Mar 12, 2018 – Mar 16, 2018) : LUPIN: Lupin closed the week on negative note losing around 4.90%....
Lupin Outlook for the Week (Mar 05, 2018 – Mar 09, 2018)
EquityPandit’s Outlook for Lupin for the week (Mar 05, 2018 – Mar 09, 2018) : LUPIN: Lupin closed the week on negative note losing around 0.50%....
Lupin Outlook for the Week (Feb 26, 2018 – Mar 02, 2018)
EquityPandit’s Outlook for Lupin for the week (Feb 26, 2018 – Mar 02, 2018) : LUPIN: Lupin closed the week on negative note losing around 2.20%....
Lupin gets approval from USFDA to market generic Tamiflu
Lupin has received final approval from the US health regulator, for its Oseltamivir Phosphate. In a BSE filing the company stated that, it has received final...
Lupin Outlook for the Week (Feb 19, 2018 – Feb 23, 2018)
EquityPandit’s Outlook for Lupin for the week (Feb 19, 2018 – Feb 23, 2018) : LUPIN: Lupin closed the week on positive note gaining around 0.40%....
Lupin introduces generic influenza treatment capsules in US
Lupin has launched generic Oseltamivir Phosphate capsules, in the US market which is used fro treating influenza. In a BSE filing the company stated that, it...